Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56 NKG2A Cells, and Yet Display Increased Degranulation and Higher Perforin Content
Overview
Authors
Affiliations
[This corrects the article on p. 798 in vol. 8, PMID: 28769923.].
Pavel-Dinu M, Gardner C, Nakauchi Y, Kawai T, Delmonte O, Palterer B Blood Adv. 2023; 8(7):1820-1833.
PMID: 38096800 PMC: 11006817. DOI: 10.1182/bloodadvances.2023011766.
Tajbakhsh A, Rahimi Jaberi K, Gheibi Hayat S, Sharifi M, Johnston T, Guest P Adv Exp Med Biol. 2021; 1327:63-78.
PMID: 34279829 DOI: 10.1007/978-3-030-71697-4_5.
Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies.
Cifaldi C, Brigida I, Barzaghi F, Zoccolillo M, Ferradini V, Petricone D Front Immunol. 2019; 10:316.
PMID: 31031743 PMC: 6470723. DOI: 10.3389/fimmu.2019.00316.